---
{"dg-publish":true,"permalink":"/research/quick-notes/2025-01-28-19-22-32/","created":"2025-06-14T23:55:14.824-04:00","updated":"2025-10-01T14:40:17.602-04:00"}
---

# Content
- A [[Research/Tags/Ketogenic Diet\|Ketogenic Diet]] can reduce the progression of [[Research/Tags/Knee\|Knee]] [[Research/Tags/Osteoarthritis\|Osteoarthritis]] via inhibition of the [[Research/Tags/NLRP3 Inflammasome\|NLRP3 Inflammasome]] in rats who maintain [[Research/Tags/Beta-Hydroxybutyrate (BHB)\|Beta-Hydroxybutyrate (BHB)]] levels ~ 3.0 mM compared to control rats with BHB levels ~0.4-0.8 mM independent of weight. Ketogenic diet protein composition ~10.9% kcal and control diet protein composition ~18.3% kcal.
# References
<div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Original Sources</span><span class="dataview small-text">1</span></th><th class="table-view-th"><span>Citations</span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Evidence Sources/kongKetogenicDietAmeliorates2022.md" data-href="Research/Evidence Sources/kongKetogenicDietAmeliorates2022.md" href="Research/Evidence Sources/kongKetogenicDietAmeliorates2022.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">kongKetogenicDietAmeliorates2022</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="M11 21.73a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16V8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73z"></path><path d="M12 22V12"></path><polyline points="3.29 7 12 12 20.71 7"></polyline><path d="m7.5 4.27 9 5.15"></path></svg></a></span></td><td><span>Kong, Ganggang, Jinyang Wang, Rong Li, Zhiping Huang, and Le Wang. “Ketogenic Diet Ameliorates Inflammation by Inhibiting the NLRP3 Inflammasome in Osteoarthritis.” Arthritis Research &amp; Therapy 24, no. 1 (May 18, 2022): 113. <a rel="noopener nofollow" class="external-link" href="https://doi.org/10.1186/s13075-022-02802-0" target="_blank">https://doi.org/10.1186/s13075-022-02802-0</a>.</span></td></tr></tbody></table></div>

# Database Fields